AI cytology tool for masses is launched

Photo: InspirationDesign/Adobe Stock

A new digital cytology tool that uses artificial intelligence (AI) to analyze lymph node and skin and subcutaneous masses in nonhuman species is now available for use with the Vetscan Imagyst, a diagnostic platform by Zoetis. The new tool, AI Masses, has the ability to detect potentially neoplastic cells accurately within minutes, according to Zoetis.¹

Leveraging deep learning algorithms, AI Masses identifies and classifies common skin and subcutaneous masses and lymph node lesions. Clinical pathologists review these insights through Digital Cytology and Add-on Expert Review functions within hours. By providing real-time insights at the point of care, the testing application helps veterinary teams with informed decisions, allowing them to better care for pet owners and veterinary patients.¹

“Our research shows that up to 75% of pet owners find abnormal results highly stressful. AI Masses is yet another point-of-care capability to deliver results in clinic, further [exemplifying] Zoetis’ purpose to advance care for animals [and] shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome,” Richard Goldstein, DVM, DACVIM (SAIM), DECVIM-CA, global chief medical officer at Zoetis said in an earlier statement.²

AI Masses is the seventh testing application for Vetscan Imagyst. Other testing applications for the platform are Digital Cytology, AI Urine Sediment, AI Fecal, AI Equine Fecal, AI Dermatology, and AI Blood Smear.²

Vetscan Imagyst works with most practice information management systems. It does not require a dedicated computer, but a high-speed connection in the clinic best supports the technology.²

“By empowering veterinary teams with valuable insights into potentially cancerous cells, we are helping to reduce waiting times and alleviate stress for pet owners facing some of the most challenging moments with their beloved pets,” Abhay Nayak, president of global diagnostics at Zoetis, said in a news release.¹ “With comprehensive digital cytology capabilities and flexible result delivery options, Vetscan Imagyst AI Masses allows veterinary practices to make timely, individualized treatment decisions.”

AI Masses was first exhibited at the 2025 Veterinary Meeting & Expo in Orlando, Florida.² It is scheduled to be shown again at the 40th World Veterinary Association Congress held in Washington, DC, in conjunction with the American Veterinary Medical Association Convention, July 18 to 22, 2025.¹

References

1. Zoetis launches AI Masses, the new AI-powered cytologic capability for Vetscan Imagyst. News release. Zoetis. June 2, 2025.
2. Bautista-Alejandre A. New AI tool for in-clinic cancer screening is announced. dvm360. February 11, 2025. Accessed June 5, 2025. https://www.dvm360.com/view/new-ai-tool-for-in-clinic-cancer-screening-is-announced